Boehringer Ingelheim Biopharmaceutical Production

The expansion of the Vienna facility has required a total investment of more than €80 million. It is the company’s largest single investment at its Austrian subsidiary.

The expansion of the Vienna facility has required a total investment of more than €80 million. It is the company’s largest single investment at its Austrian subsidiary.


client logon
Home
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?